Dynex Capital faces pressure amid global market turmoil
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 12 2026
0mins
Should l Buy DX?
Source: Coinmarketcap
Dynex Capital Inc's stock has dropped significantly, hitting a 20-day low amid a broader market decline.
The ongoing U.S.-Iran conflict has led to severe pressure on real estate stocks, with investors moving away from rate-sensitive names towards safer bets, resulting in many stocks, including Dynex Capital, experiencing heavy selling pressure. The Nasdaq-100 and S&P 500 are both down over 1%, indicating a broader market weakness that has affected investor sentiment.
This decline reflects the current market dynamics where real estate stocks are particularly vulnerable, and investors are likely to remain cautious until geopolitical tensions ease.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DX
Wall Street analysts forecast DX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 12.460
Low
14.50
Averages
15.25
High
16.00
Current: 12.460
Low
14.50
Averages
15.25
High
16.00
About DX
Dynex Capital, Inc. is a financial services company. The Company is an internally managed mortgage real estate investment trust (REIT), which invests in mortgage-backed securities (MBS). It finances its investments principally with repurchase agreements. Its objective is to provide attractive risk-adjusted returns to its shareholders over the long term that are reflective of a leveraged, high-quality fixed income portfolio with a focus on capital preservation. It seeks to provide returns to its shareholders primarily through the payment of regular dividends and through capital appreciation of its investments. It primarily invests in Agency MBS, of which over 97% are residential MBS (Agency RMBS), including to-be-announced (TBA) securities. The remainder of its investment portfolio consists of Agency commercial MBS (Agency CMBS) and Agency and non-Agency CMBS interest-only (CMBS IO) securities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Global Market Turmoil as Real Estate Stocks Face Pressure
- Market Turmoil: The ongoing U.S.-Iran conflict has led to significant global market turmoil, with nearly $2 trillion in market value wiped out over the past month, exacerbating investor anxiety and pulling U.S. stocks lower.
- Real Estate Pressure: Real estate stocks have come under severe pressure as investors moved away from rate-sensitive names towards safer bets, resulting in several real estate stocks falling into oversold territory with RSI indicators in the 20-30 range, indicating heavy selling pressure.
- Oversold Stocks: Tritax Big Box (TTBXF) and Vornado Realty Trust (VNO) are highlighted as the most oversold real estate stocks, with RSIs of 22 and 28 respectively, suggesting extreme selling pressure, and they could be among the first to see a technical rebound if geopolitical tensions ease.
- Trading Dynamics: SL Green Realty's divestiture of the residential and retail segments of 7 Dey Street for $222.6 million illustrates that despite market turmoil, trading activity persists, reflecting investors' search for opportunities while adjusting their asset allocations.
See More
Dynex Capital Declares Cash Dividends for March 2026
- Dividend Declaration: Dynex Capital announced a cash dividend of $0.17 per share on its common stock for March 2026, reflecting the company's ongoing profitability and commitment to shareholder returns.
- Preferred Stock Dividend: The company also declared a quarterly cash dividend of $0.58711 per share for its Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, enhancing its appeal in the capital markets.
- Preferred Dividend Rate: The dividend rate for the Series C Preferred shares is set at 9.39374%, indicating the company's ability to offer competitive returns in the current interest rate environment, which may attract more investor interest.
- Company Overview: Dynex Capital is a REIT focused on high-quality mortgage assets, and through disciplined risk management, it has consistently delivered attractive dividends, strengthening its market position.
See More
Analysis of Insider Buying in Kingsbarn ETF
- Insider Buying Ratio: The Kingsbarn Dividend Opportunity ETF (DVDN) shows that 18.0% of its weighted holdings have experienced insider buying in the past six months, indicating management's confidence in future growth, which may attract more investor interest in the ETF.
- Arbor Realty Trust Activity: Arbor Realty Trust Inc (ABR), making up 7.24% of DVDN, has seen 4 directors and officers purchase shares in the past six months, reflecting optimism among insiders about the company's future performance, potentially boosting market confidence in the stock.
- Dynex Capital Purchases: Dynex Capital Inc (DX), the fifth largest holding in DVDN, has $185,144 worth of shares held in the ETF, representing approximately 6.05% of total assets, with 2 directors and officers recently filing Form 4s, indicating insider optimism that could influence the stock's price trajectory.
- ETF Investment Strategy: The increase in insider buying activity within the Kingsbarn Dividend Opportunity ETF's portfolio may enhance its overall investment appeal, especially in the current market environment where investors are likely to favor stocks that insiders are optimistic about.
See More
Dynex Capital Appoints New CFO Michael Sartori
- Executive Change: Dynex Capital has appointed Michael Sartori as Chief Financial Officer, effective immediately, indicating a strategic shift in the company's approach to capital markets and financial planning aimed at enhancing financial management efficiency.
- Transition Support: Former CFO Robert Colligan will remain in an advisory role until May 1, 2026, facilitating a smooth transition for the management team, which is crucial for maintaining investor confidence and operational stability.
- Market Concerns: Despite Dynex Capital's earnings performance attracting attention, market analysts express skepticism regarding the sustainability of its high yield, which could impact investor perceptions of the company's future financial health.
- Capital Raising: Dynex Capital's recent $1.5 billion capital raise signals the company's intent to adopt a tighter spread management strategy in the current economic environment, aiming to enhance shareholder returns, which have reached 29.4%.
See More
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
Global Market Turmoil as Real Estate Stocks Face Pressure
- Market Turmoil: The ongoing U.S.-Iran conflict has led to significant global market turmoil, with nearly $2 trillion in market value wiped out over the past month, exacerbating investor anxiety and pulling U.S. stocks lower.
- Real Estate Pressure: Real estate stocks have come under severe pressure as investors moved away from rate-sensitive names towards safer bets, resulting in several real estate stocks falling into oversold territory with RSI indicators in the 20-30 range, indicating heavy selling pressure.
- Oversold Stocks: Tritax Big Box (TTBXF) and Vornado Realty Trust (VNO) are highlighted as the most oversold real estate stocks, with RSIs of 22 and 28 respectively, suggesting extreme selling pressure, and they could be among the first to see a technical rebound if geopolitical tensions ease.
- Trading Dynamics: SL Green Realty's divestiture of the residential and retail segments of 7 Dey Street for $222.6 million illustrates that despite market turmoil, trading activity persists, reflecting investors' search for opportunities while adjusting their asset allocations.
See More
Dynex Capital Declares Cash Dividends for March 2026
- Dividend Declaration: Dynex Capital announced a cash dividend of $0.17 per share on its common stock for March 2026, reflecting the company's ongoing profitability and commitment to shareholder returns.
- Preferred Stock Dividend: The company also declared a quarterly cash dividend of $0.58711 per share for its Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, enhancing its appeal in the capital markets.
- Preferred Dividend Rate: The dividend rate for the Series C Preferred shares is set at 9.39374%, indicating the company's ability to offer competitive returns in the current interest rate environment, which may attract more investor interest.
- Company Overview: Dynex Capital is a REIT focused on high-quality mortgage assets, and through disciplined risk management, it has consistently delivered attractive dividends, strengthening its market position.
See More
Analysis of Insider Buying in Kingsbarn ETF
- Insider Buying Ratio: The Kingsbarn Dividend Opportunity ETF (DVDN) shows that 18.0% of its weighted holdings have experienced insider buying in the past six months, indicating management's confidence in future growth, which may attract more investor interest in the ETF.
- Arbor Realty Trust Activity: Arbor Realty Trust Inc (ABR), making up 7.24% of DVDN, has seen 4 directors and officers purchase shares in the past six months, reflecting optimism among insiders about the company's future performance, potentially boosting market confidence in the stock.
- Dynex Capital Purchases: Dynex Capital Inc (DX), the fifth largest holding in DVDN, has $185,144 worth of shares held in the ETF, representing approximately 6.05% of total assets, with 2 directors and officers recently filing Form 4s, indicating insider optimism that could influence the stock's price trajectory.
- ETF Investment Strategy: The increase in insider buying activity within the Kingsbarn Dividend Opportunity ETF's portfolio may enhance its overall investment appeal, especially in the current market environment where investors are likely to favor stocks that insiders are optimistic about.
See More
Dynex Capital Appoints New CFO Michael Sartori
- Executive Change: Dynex Capital has appointed Michael Sartori as Chief Financial Officer, effective immediately, indicating a strategic shift in the company's approach to capital markets and financial planning aimed at enhancing financial management efficiency.
- Transition Support: Former CFO Robert Colligan will remain in an advisory role until May 1, 2026, facilitating a smooth transition for the management team, which is crucial for maintaining investor confidence and operational stability.
- Market Concerns: Despite Dynex Capital's earnings performance attracting attention, market analysts express skepticism regarding the sustainability of its high yield, which could impact investor perceptions of the company's future financial health.
- Capital Raising: Dynex Capital's recent $1.5 billion capital raise signals the company's intent to adopt a tighter spread management strategy in the current economic environment, aiming to enhance shareholder returns, which have reached 29.4%.
See More
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
